Dieter Natlacen

Open Source in Healthcare and Life Sciences – Legal Framework and Compliance Requirements

par Jan Feuerhake, LL.M. (Melbourne) et Gabriel Danyeli, LL.M. (Köln/Istanbul Bilgi)

The UPC’s first referral to the European Court of Justice: Cross-border preliminary injunctions against intermediaries and non-UPC defendants

par plusieurs auteurs

Hungarian supreme court on legal standing to challenge generic marketing authorisations

par Fruzsina Kónya

Case law – VfGH on the eImpfpass and central vaccination register

par Christopher Bakier

The new Product Liability Directive: three life sciences priorities before the 2026 deadline

par Bartosz Świdrak

Update: AI-Enabled Medical Devices and IVDs Confirmed as “High-Risk”

par Irina Rebin

Poland’s new AI systems act: a regulator and practical tools

par Bartosz Świdrak

Medical Cannabis Platforms Breach Advertising Ban

par Irina Rebin

Life Sciences Legal Lens Vol. 2

CJEU on distributor's verification obligations under MDR

par Irina Rebin